Navigation Links
Blood Protein Might Signal Death Risk in Elderly
Date:8/30/2011

By Amanda Gardner
HealthDay Reporter

TUESDAY, Aug. 30 (HealthDay News) -- Swedish scientists have identified a protein circulating in the blood which seems to be a harbinger of an increased risk of death among elderly people.

The protein, cathepsin S, is strongly tied to the inflammatory processes that are central to killers such as cancer and heart disease.

The authors of the new study, published online Aug. 30 in the Journal of the American Medical Association and simultaneously being presented at the European Society of Cardiology Congress in Paris, suggest that the protein might be a target for drugs, some of which are already being tested in trials.

In theory, such a biomarker could also "help us interpret how to direct health care," said Thomas Mariani, an associate professor of pediatrics, medicine and environmental medicine at the University of Rochester Medical Center.

But widespread use of the marker is still a ways away, Mariani added.

Previous studies have found higher levels of cathepsin S, an enzyme, in patients who are obese or who have diabetes or heart disease. Patients who lose weight reportedly have lower levels of cathepsin S.

Researchers have speculated that the protein may be involved in the development of atherosclerosis. It may also cause cancer tumors to develop and spread.

The authors of the study, from Uppsala University in Sweden, correlated cathepsin S levels with mortality in two groups of elderly people.

The first group consisted of 1,000 men in Uppsala with an average age of 71 who were followed for an average of 13 years.

The second group also consisted of 1,000 people of about the same age, this time half women and half men. They were followed for about eight years.

Even after adjusting for factors such as age, blood pressure, diabetes, smoking, weight, cholesterol levels and history of heart disease, men in the first group who had the highest levels of cathepsin S in their blood had a 60 percent increased risk of death compared to those with the lowest levels.

High cathepsin S levels were also associated with a 62 percent increased risk of death from cardiovascular disease and a small increase in death from cancer.

In the second group, men and women who showed the highest levels of the protein in their blood had double the risk of dying when compared to those with the lowest levels.

It's too early to say if there's a cause-and-effect relationship, Mariani cautioned.

Nor is it clear if the findings can be generalized to other ethnic groups (this was mostly a white European population) or other age groups.

The biomarker does seem promising because it would be easy to assess in a simple blood test. Still, it needs to be validated in further trials.

"Future studies should be performed on medications [to target this biomarker]. They need to see if intervening on this particular marker actually will improve outcomes," said Dr. Suzanne Steinbaum, director of Women and Heart Disease at the Heart and Vascular Institute at Lenox Hill Hospital in New York City.

More information

Visit the American Heart Association for more on cardiovascular disease.

SOURCES: Thomas Mariani, Ph.D., associate professor, pediatrics, medicine and environmental medicine, University of Rochester Medical Center; Suzanne Steinbaum, D.O., director, Women and Heart Disease, Heart and Vascular Institute, Lenox Hill Hospital, New York City; Aug. 30, 2011, Journal of the American Medical Association, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Poor Sleep, High Blood Pressure?
2. New Blood Thinner May Outperform Warfarin for Irregular Heartbeat
3. Stanford researchers invent sutureless method for joining blood vessels
4. C-Sections Linked to Doubled Risk for Blood Clots
5. FDA clears new IMMY and University of Nevada, Reno life-saving blood test
6. Common vein condition increases risk for developing life-threating blood clots
7. Blood Antibody May Signal Start of Ovarian Cancer
8. Central Catheters May Raise Risk of Blood Clots After Surgery
9. Study Pits New Blood Thinner Against Warfarin For Irregular Heartbeat
10. Study finds popular muscle-boosting supplement does not increase blood flow
11. Maternal Blood Test Can Determine Sex of Fetus at 7 Weeks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Protein Might Signal Death Risk in Elderly
(Date:11/30/2016)... ... November 30, 2016 , ... The Fertility Centers of ... a Cigna Infertility Center of Excellence. The Cigna Center of Excellence recognizes participating ... honor to be designated a Cigna Infertility Center of Excellence," said Fertility Centers ...
(Date:11/30/2016)... , ... November 30, 2016 , ... "I hate when ... arm while brushing my teeth," said an inventor from Bridgewater, N.J. "I thought that ... develop this handy device." , He developed the patent-pending DEFLECTOR to prevent saliva and ...
(Date:11/30/2016)... Palm Beach Gardens, FL (PRWEB) , ... November ... ... leader in eating disorder and mental health treatment has announced the opening of ... facility provides specialized partial hospitalization and intensive outpatient treatment for adults and adolescents, ...
(Date:11/30/2016)... ... November 30, 2016 , ... In ... been a focus of public policymakers and system stakeholders in many states. To ... its Medical Price Index for Workers’ Compensation, Eighth Edition (MPI-WC) . , ...
(Date:11/30/2016)... ... 2016 , ... The Clinical Data Interchange Standards Consortium (CDISC) ... goes into effect next month. Sponsors whose studies start after December 17, 2016 ... The current FDA Data Standards Catalog specifies the use of CDISC standards: ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016 On Thursday, the NASDAQ Composite ... while the Dow Jones Industrial Average managed to stay in ... markets, which prompted Stock-callers this morning to look at the ... NUVA ), Smith & Nephew PLC (NYSE: ... and Cesca Therapeutics Inc. (NASDAQ: KOOL ). You ...
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... , Dec. 2, 2016 Allergan plc (NYSE: ... provided additional information on its previously announced Accelerated Share Repurchase ... ... As previously announced, the Company entered ... under which the Company will repurchase $10 billion of its ...
Breaking Medicine Technology: